1 results match your criteria: "Canada.. Electronic address: acontreras@prostatecentre.com.[Affiliation]"
A systematic review of nanocarriers for treatment of urologic cancers.
Urol Oncol
April 2024
The Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.. Electronic address:
Nanocarriers (NCs) are a form of nanotechnology widely investigated in cancer treatment to improve the safety and efficacy of systemic therapies by increasing tumor specificity. Numerous clinical trials have explored the use of NCs in urologic cancers since the approval of the first NCs for cancer treatment over 20 years ago. The objective of this systematic review is to examine the effectiveness and safety of NCs in treating urological cancers.
View Article and Find Full Text PDF